SOLTI is a leading academic research group in Oncology that develops clinical trials of excellence. Established in 1995, it has focused its efforts on developing national and international clinical trials and incorporating innovative translational research in all the projects in which it participates.
Currently, it has more than 400 members, as well as more than 80 sites distributed in Spain, Portugal, France and Italy.
Through the promotion of strategic alliances, patient empowerment, and excellence in clinical and translational research that translates into numerous high-impact scientific publications, SOLTI has become a benchmark in breast cancer in particular and aims to fulfill this role also in other types of tumors.
As an association, SOLTI has the following representative bodies:
- General Assembly Members
The General Assembly is formed by more than 400 oncologists and health professionals involved in the development of clinical trials that are associated with the group.
- Board Members
- Board Honorific Member:
Dr Ana Casas - Fundación Actitud Frente al Cáncer
- SOLTI statutes: